Quebec Metastatic Breast Cancer Registry
The Quebec Metastatic Breast Cancer Registry
The Canadian Cancer Society (CCS) and McPeak-Sirois Group are working to grow the Quebec Metastatic Breast Cancer Registry. By encouraging the development of standardized data, we can improve care for people with cancer, promote strong research practices and enhance information sharing.
The Registry will allow the collection and sharing of data in a way that has never been done before in Canada, which could improve the health and well-being of people with breast cancer.
What is the Quebec Metastatic Breast Cancer Registry? @(Model.HeadingTag)>
Initiated by the Scientific Committee of the McPeak-Sirois Group, and under the leadership of Dr Sarkis Meterissian, the Registry is the first in Quebec. This foremost initiative, in partnership with the Ministère de la Santé et des Services sociaux (MSSS) and the Direction nationale du Programme québécois de cancérologie du Québec.
The Registry launched in 2021 with 3 participating hospitals: McGill University Health Centre, the Centre hospitalier de l’Université de Montréal and the CHU de Québec-Université Laval. In 2023, all other hospitals that are members of the Group in Quebec will be able to contribute to the project.
CCS is providing $2.5 million over 5 years to expand the Registry, with the goal of eventually including all types of breast cancer in Quebec.
Why is the Registry important? @(Model.HeadingTag)>
The Registry also fosters collaboration between researchers and gives them access to crucial patient data needed to understand how people with metastatic breast cancer are treated in Quebec and how they respond to that treatment.